Cell & Gene Therapy 2018 is to be held on 9th April,2018

9-10 April,2018 ∣ Kuala Lumpur, Malaysia

Website: https://biotechpharmasummit.com/index.php/event/cell-gene-therapy-2018/

 

About Conference:

On 9 & 10 April 2018, Kuala Lumpur in Malaysia, will host the BioTech Pharma Summit: Cell & Gene Therapy 2018 conference. This year’s event is bringing together academia and industry to showcase several new technologies emerging in the field of cell and gene therapy. The BioTech Pharma Summit: Cell & Gene Therapy 2018 is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.

Why to Attend?

 

This two-day Cell & Gene Therapy 2018 will address key issues concerning cell therapy & gene therapy research in the broader context of cellular and genetic disorder. Organized around daily themes, this conference focuses on moving from present knowledge to future solutions thus imparting the knowledge growth and awareness among people.

Target Audience:

• Cell Therapy Research
• Manufacturing Innovation
• Global Medical Affairs
• CMC
• Health economics
• Strategic Marketing
• Regulatory Affairs
• Regenerative Medicine
• Advanced Therapy Production
• Gene Therapy Development
• Clinical Platform Development
• Cellular Therapy Immuno-Oncology
• Manufacturing and R&D
• Quality Control
• GMP
• Global Pricing and Market Access
• Cell & Tissue Therapy
• Biotechnologists
• Immunologists
• Pricing &Reimbursement
• Payer Strategy
• Payer Marketing
• National Account Managers
• Advanced Therapy Production

 

Conference Highlights:

 

• Perspectives on adjustments and Bio-Quality of Cell & Gene Therapy Bioprocessing
• Future Enhancements of Manufacturing Technologies
• Preclinical Development of Novel Technologies
• Identify the Opportunities and Challenges in Advanced Therapy Manufacturing Process
• Regulatory insight on ATMP Development
• Future Vision of Gene Therapy Production
• Cell, Gene and Immunotherapy Manufacturing
• Automation and Cold Chain
• Funding and Regulatory Challenges
• Cell, Gene and Immunotherapy USP, DSP, PAT and Analytics
• Preclinical Strategies for Cell, Gene and Immunotherapies
• Clinical Development for Cell, Gene and Immunotherapies
• Emerging Cell Therapy Treatments
• Analytical Testing and Quality System
• Product Development and Commercialization

 

Contact us

 

Diogo Lino Ribeiro

Tel: +351 915 239 640

Email: diogo.ribeiro@epmgroup.org